Royal Bank Of Canada Pharma Cyte Biotech, Inc. Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.55 - $2.16 $3 - $4	-2 Reduced 2.0%	98 $0
Q3 2024 Nov 14, 2024	SELL	$1.47 - $2.18 $236 - $350	-161 Reduced 61.69%	100 $0
Q2 2024 Aug 14, 2024	BUY	$1.95 - $2.52 $204 - $264	105 Added 67.31%	261 $0
Q1 2024 Nov 05, 2024	SELL	$1.95 - $2.48 $204 - $260	-105 Reduced 40.23%	156 $0
Q1 2024 May 15, 2024	SELL	$1.95 - $2.48 $212 - $270	-109 Reduced 41.13%	156 $0
Q4 2023 Feb 14, 2024	BUY	$2.01 - $2.34 $335 - $390	167 Added 170.41%	265 $0
Q4 2022 Feb 14, 2023	SELL	$2.39 - $3.07 $126 - $162	-53 Reduced 35.1%	98 $0
Q3 2022 Nov 14, 2022	BUY	$2.24 - $2.85 $118 - $151	53 Added 54.08%	151 $0
Q4 2021 Feb 14, 2022	SELL	$2.4 - $3.19 $1,353 - $1,799	-564 Reduced 85.2%	98 $0
Q3 2021 Nov 15, 2021	BUY	$2.28 - $16.9 $1,509 - $11,187	662 New	662 $2,000

674K

13.7K

2.1K

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $19.9M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.